Study guide
12.2 Adaptive Immunity: T-Cell & B-Cell Activation, MHC Restriction, and Antibodies
NPLEX Part I — Biomedical Sciences Study Guide Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Exam Structure, Pacing, and GEA Strategy
1.1 Overview of NPLEX Part I & NABNE Exam Structure 1.2 Deconstructing Biomedical Clinical Vignettes 1.3 General Exam Areas (GEAs) & Passing Standards
2 Chapter 2: Gross Anatomy & Musculoskeletal System
2.1 Musculoskeletal Anatomy of Upper and Lower Extremities 2.2 Structural Anatomy of Head, Neck, Thorax, and Abdomen 2.3 Pelvic Architecture, Perineal Anatomy, and Articular Structures
3 Chapter 3: Histology & Microscopic Anatomy
3.1 Histology of Epithelial, Connective, and Muscular Tissues 3.2 Microscopic Structure of Gastrointestinal, Renal, and Endocrine Organs 3.3 Microscopic Anatomy of Integument, Lymphoid Tissues, and Respiratory Epithelium
4 Chapter 4: Neuroanatomy & Special Senses
4.1 Cranial Nerves, Nuclei, and Peripheral Distribution 4.2 Spinal Cord Tracts, Brainstem Circuits, and Motor/Sensory Pathways 4.3 Cerebral Cortex, Basal Ganglia, Limbic System, and Autonomic Nervous System 4.4 Neuroanatomy of Vision, Audition, Vestibular Function, and Olfaction/Gustation
5 Chapter 5: Embryology & Developmental Anatomy
5.1 Gametogenesis, Fertilization, Blastulation, and Germ Layer Derivatives 5.2 Organogenesis: Cardiovascular and Respiratory System Development 5.3 Gastrointestinal, Urogenital, and Craniofacial Embryology
6 Chapter 6: Cellular & General Physiology
6.1 Membrane Transport Mechanics, Resting Potentials, and Ion Channels 6.2 Action Potential Propagation and Synaptic Transmission 6.3 Excitation-Contraction Coupling in Skeletal, Cardiac, and Smooth Muscle
7 Chapter 7: Cardiovascular & Respiratory Physiology
7.1 Cardiac Electrophysiology, ECG, and Mechanical Cardiac Cycle 7.2 Hemodynamics, Peripheral Resistance, and Blood Pressure Control 7.3 Pulmonary Mechanics, Lung Volumes, and Gas Exchange Dynamics 7.4 Transport of Oxygen/CO2 and Neural/Chemical Control of Breathing
8 Chapter 8: Renal, Fluid, & Acid-Base Physiology
8.1 Glomerular Filtration Rate and Tubular Reabsorption/Secretion Mechanics 8.2 Countercurrent Multiplication, Osmoregulation, and Urine Concentration 8.3 Body Fluid Compartments, Sodium/Water Homeostasis, and Potassium Dynamics 8.4 Renal & Respiratory Acid-Base Regulation and Compensation Mechanisms
9 Chapter 9: Gastrointestinal, Endocrine, & Reproductive Physiology
9.1 GI Motility, Secretory Functions, Digestion, and Nutrient Absorption 9.2 Hypothalamic-Pituitary Axes, Adrenal Gland, and Thyroid Physiology 9.3 Endocrine Pancreas, Glucose Regulation, Calcium/Phosphate Homeostasis 9.4 Male and Female Reproductive Endocrinology and Menstrual Cycle Regulation
10 Chapter 10: Enzymology, Bioenergetics, & Carbohydrate/Lipid Metabolism
10.1 Enzyme Kinetics, Catalytic Mechanisms, and Vitamin Cofactors 10.2 Glycolysis, Pyruvate Dehydrogenase, TCA Cycle, and Oxidative Phosphorylation 10.3 Glycogen Metabolism, Gluconeogenesis, and Pentose Phosphate Pathway 10.4 Fatty Acid Synthesis, Beta-Oxidation, Ketogenesis, and Lipoprotein Transport
11 Chapter 11: Amino Acid/Nucleotide Metabolism & Clinical Genetics
11.1 Amino Acid Degradation, Transamination, and Urea Cycle Disorders 11.2 Purine and Pyrimidine Synthesis, Salvage, and Gout Pathophysiology 11.3 Mendelian Inheritance, Chromosomal Abnormalities, and Molecular Genetics
12 Chapter 12: Immunology & Immunopathology
12.1 Innate Immune Barriers, Phagocytosis, Cellular Pattern Recognition, and Complement System 12.2 Adaptive Immunity: T-Cell & B-Cell Activation, MHC Restriction, and Antibodies 12.3 Types I-IV Hypersensitivity Reactions and Mechanisms of Autoimmunity 12.4 Immunodeficiency Syndromes, Tumor/Transplant Immunology, and Vaccine Types
13 Chapter 13: Medical Microbiology
13.1 Medical Bacteriology: Gram-Positive, Gram-Negative, and Atypical Bacteria 13.2 Medical Virology: DNA, RNA, Retroviruses, and Viral Pathogenesis 13.3 Medical Mycology: Cutaneous, Systemic, and Opportunistic Fungal Infections 13.4 Medical Parasitology: Protozoan and Helminthic Pathogens
14 Chapter 14: General Pathology & Neoplasia
14.1 Cellular Adaptation, Reversible/Irreversible Injury, Necrosis, and Apoptosis 14.2 Acute and Chronic Inflammation, Chemical Mediators, and Tissue Healing 14.3 Neoplasia: Benign vs Malignant Features, Carcinogenesis, Oncogenes, and Tumor Suppressors
15 Chapter 15: Systems Pathology & Disease Mechanisms
15.1 Pathophysiology of Atherosclerosis, Heart Failure, COPD, and Pneumonias 15.2 Glomerulonephritis, Inflammatory Bowel Disease, and Hepatorenal Disease Pathophysiology 15.3 Endocrine Disorders, Neurodegenerative Pathology, and Epidemiological Principles 15.4 Hematopoietic System Pathology: Anemias, Coagulopathies, and Hematologic Neoplasms 15.5 Immunological System Pathology: Autoimmune, Amyloid, and Systemic Immune-Mediated Disease 15.6 Integumentary System Pathology: Inflammatory Dermatoses, Blistering Disorders, and Skin Neoplasms 15.7 Musculoskeletal System Pathology: Metabolic Bone Disease, Arthropathies, and Bone Neoplasms 15.8 Reproductive System Pathology: Endocrine, Inflammatory, and Neoplastic Disorders of the Reproductive Tract
12.2 Adaptive Immunity: T-Cell & B-Cell Activation, MHC Restriction, and Antibodies
Key Takeaways Explain This Topic AI
MHC Class I (HLA-A, B, C) is expressed on all nucleated cells, presenting intracellular antigens processed via TAP to CD8+ cytotoxic T cells, whereas MHC Class II (HLA-DP, DQ, DR) is expressed on professional APCs, presenting extracellular antigens to CD4+ helper T cells.
T-cell maturation in the thymus involves positive selection in the cortex (ensuring self-MHC restriction) and negative selection in the medulla (deleting autoreactive T cells mediated by the AIRE gene).
CD4+ T helper cell differentiation yields distinct functional subsets: Th1 (cell-mediated, IFN-gamma), Th2 (humoral/helminth/allergy, IL-4/IL-5/IL-13), Th17 (mucosal/fungal, IL-17/IL-22), and Treg (suppressive, FOXP3).
B-cell receptor diversity is generated by V(D)J recombination (RAG1/RAG2), while class switch recombination and somatic hypermutation require CD40L-CD40 interaction and the enzyme AID.
Last updated: July 2026
12.2 Adaptive Immunity: T-Cell & B-Cell Activation, MHC Restriction, and Antibodies
Adaptive immunity provides antigen-specific protection characterized by clonal expansion of antigen-reactive lymphocytes and the generation of immunological memory. The major executioners of adaptive immunity are T lymphocytes (cell-mediated immunity) and B lymphocytes (humoral immunity).
Major Histocompatibility Complex (MHC) Architecture
The Major Histocompatibility Complex (MHC), known in humans as the Human Leukocyte Antigen (HLA) complex, encodes cell-surface glycoproteins that present peptide fragments to T-cell receptors (TCRs). +------------------------+-----------------------------------+-----------------------------------+
- | Feature | MHC Class I | MHC Class II |
- +------------------------+-----------------------------------+-----------------------------------+
- | HLA Genes | HLA-A, HLA-B, HLA-C | HLA-DP, HLA-DQ, HLA-DR |
- | Cellular Distribution | All nucleated cells (absent RBCs) | Professional APCs (Dendritic, |
- | | | Macrophages, B cells) |
- | Molecular Structure | Alpha chain (a1, a2, a3) + | Alpha chain (a1, a2) + |
- | | beta-2 microglobulin | Beta chain (b1, b2) |
- | Antigen Source | Intracellular / Endogenous | Extracellular / Exogenous |
- | | (viral, mutated tumor proteins) | (phagocytosed bacteria, toxins) |
- | Processing Machinery | Proteasome, TAP transporter | Endolysosome, Invariant chain, |
- | | | CLIP, HLA-DM |
- | Responding Lymphocyte | CD8+ Cytotoxic T cells | CD4+ Helper T cells |
- | T-Cell Co-receptor Site| CD8 binds a3 domain | CD4 binds b2 domain |
- +------------------------+-----------------------------------+-----------------------------------+
- MHC Class I Pathway (Endogenous Antigen Presentation)
Intracellular proteins (e.g., viral proteins synthesized in the cytosol or mutated self-proteins) are ubiquitinated and degraded by the proteasome .
Peptides are transported into the lumen of the endoplasmic reticulum (ER) via the TAP (Transporter associated with Antigen Processing) protein complex.
Peptides are loaded into the peptide-binding groove of newly synthesized MHC Class I heavy chains complexed with β 2 \beta_2 β 2 -microglobulin .
The MHC I-peptide complex is transported to the plasma membrane and presented to CD8+ Cytotoxic T Lymphocytes (CTLs) .
MHC Class II Pathway (Exogenous Antigen Presentation)
Extracellular pathogens or proteins are internalized by endocytosis or phagocytosis into endosomes/lysosomes and degraded into peptide fragments by acid proteases.
In the ER, newly synthesized MHC Class II α β \alpha\beta α β heterodimers bind the Invariant Chain ( I i I_i I i ) , which blocks premature peptide binding in the ER and directs the MHC Class II molecule into late endosomal compartments.
Within the endosome, the invariant chain is cleaved, leaving a small fragment called CLIP (Class II-associated invariant chain peptide) in the binding groove.
HLA-DM catalyzes the removal of CLIP, allowing exogenous antigenic peptides to bind the MHC Class II groove.
The MHC Class II-peptide complex travels to the cell surface for presentation to CD4+ Helper T cells .
T-Cell Development and Differentiation
T-cell progenitor cells migrate from the bone marrow to the thymus , where they undergo TCR gene rearrangement and stringent selection processes.
Thymic Selection (Central Tolerance)
Positive Selection (Thymic Cortex): Double-positive ( C D 4 + C D 8 + CD4^+CD8^+ C D 4 + C D 8 + ) immature thymocytes interact with cortical thymic epithelial cells presenting self-peptides on MHC Class I and Class II. Thymocytes whose TCR recognizes self-MHC with moderate affinity receive survival signals (MHC restriction). Thymocytes that bind MHC Class I downregulate CD4 to become C D 8 + CD8^+ C D 8 + single-positive cells; those that bind MHC Class II downregulate CD8 to become C D 4 + CD4^+ C D 4 + single-positive cells. Cells unable to bind self-MHC undergo apoptosis ("death by neglect").
Negative Selection (Thymic Medulla): Single-positive thymocytes encounter medullary thymic epithelial cells (mTECs) and dendritic cells. mTECs express the AIRE (Autoimmune Regulator) gene, which drives ectopic transcription of tissue-restricted self-antigens (e.g., insulin, thyroid proteins). Thymocytes displaying high-affinity binding to self-MHC/self-antigen complexes undergo apoptotic deletion or convert into regulatory T cells. Mutations in AIRE cause APECED / APS-1 (Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy).
CD4+ T Helper Subsets
Upon encountering antigen on APCs, naive CD4+ T helper ( T h 0 Th0 T h 0 ) cells differentiate into specialized effector subsets dictated by the local cytokine environment: +---> Th1 (IL-12, IFN-g) --> IFN-g, IL-2 [Macrophage activation, Intracellular pathogens]
- |
- +---> Th2 (IL-4) --> IL-4, 5, 13 [Helminths, Allergy, IgE class switch]
- Naive CD4+ T cell --|
- +---> Th17 (IL-6, TGF-b) --> IL-17, IL-22 [Extracellular bacteria/fungi, Neutrophils]
- |
- +---> Treg (TGF-b) --> IL-10, TGF-b [Immune suppression, Peripheral tolerance]
Th1 Subsets: Induced by IL-12 and IFN- γ \gamma γ (transcription factor T-bet ). Secretes IFN- γ \gamma γ and IL-2 . IFN- γ \gamma γ activates macrophages (enhancing phagolysosomal killing), promotes IgG2a/IgG3 opsonizing antibody production, and mediates cell-mediated immunity against intracellular pathogens ( Mycobacterium tuberculosis , Leishmania ).
Th2 Subsets: Induced by IL-4 (transcription factor GATA-3 ). Secretes IL-4 , IL-5 , and IL-13 . IL-4 and IL-13 drive B-cell class switching to IgE ; IL-5 stimulates eosinophil growth and activation. Mediates defense against helminthic parasites and drives Type I hypersensitivity (allergic) reactions.
Th17 Subsets: Induced by IL-6 , TGF- β \beta β , and IL-23 (transcription factor ROR γ t \gamma t γ t ). Secretes IL-17 and IL-22 . IL-17 recruits neutrophils to clear extracellular bacterial and fungal infections ( Candida albicans ). Mutations in STAT3 impair Th17 generation, causing Hyper-IgE Syndrome (Job Syndrome) (cold staph abscesses, eczema, retained primary teeth).
Treg Subsets: Phenotype C D 4 + C D 25 + FOXP3 + CD4^+CD25^+\text{FOXP3}^+ C D 4 + C D 2 5 + FOXP3 + (transcription factor FOXP3 ). Secretes anti-inflammatory cytokines IL-10 and TGF- β \beta β . Maintains peripheral self-tolerance and suppresses autoreactive T-cell responses. Mutations in FOXP3 lead to IPEX Syndrome (Immunodysregulation Polyendocrinopathy Enteropathy X-linked).
B-Cell Activation and Antibody Isotypes
B cells develop in the bone marrow, where immunoglobulin heavy and light chain genes undergo somatic rearrangement.
Somatic Recombination and B-Cell Activation
V(D)J Recombination: In the bone marrow, RAG-1 and RAG-2 (Recombination Activating Genes) randomly recombine Variable (V), Diversity (D), and Joining (J) gene segments for the heavy chain, and V and J segments for the light chain ( κ \kappa κ or λ \lambda λ ). Terminal deoxynucleotidyl transferase (TdT) inserts non-templated nucleotides at gene junctions, maximizing antigen receptor diversity.
T-Cell-Dependent B-Cell Activation: Mature naive B cells internalize antigen via surface IgM/IgD, processing and presenting peptides on MHC Class II to activated CD4+ T follicular helper ( T F H T_{FH} T F H ) cells. Interaction requires two signals:
TCR binding to MHC II-peptide complex.
CD40L (CD154) on T cell binding to CD40 on B cell.
Class Switch Recombination (CSR) & Somatic Hypermutation (SHM): T-cell-derived cytokines (IL-4, IFN- γ \gamma γ , TGF- β \beta β ) and CD40 ligation induce the enzyme Activation-Induced Cytidine Deaminase (AID) in lymph node germinal centers. AID mediates class switching of the heavy chain constant region from C μ C_\mu C μ to C γ , C α , or C ϵ C_\gamma, C_\alpha, \text{or } C_\epsilon C γ , C α , or C ϵ , and introduces point mutations in variable regions (somatic hypermutation) to select high-affinity antibodies ( affinity maturation ). Defects in CD40L cause Hyper-IgM Syndrome .
Immunoglobulin Structure and Isotypes
Antibodies consist of two identical heavy (H) chains and two identical light (L) chains connected by disulfide bonds. The Fab region (variable domain) binds antigen; the Fc region (constant domain) dictates biological isotype function (complement fixation, Fc receptor binding). Fab Region (Antigen Binding)
- \ /
- \ /
- +---+ <-- Disulfide Hinge
- | |
- | |
- Fc Region (Complement Fixation & Fc Receptor Binding)
IgG: Monomer. Most abundant serum immunoglobulin (~75–80%). Longest serum half-life (~21 days). Only antibody class that crosses the placenta , conferring passive immunity to the fetus. Predominates in secondary (anamnestic) immune responses. Acts as a major opsonin and activates classical complement.
IgA: Monomer in serum; dimer joined by a J-chain in mucosal secretions (tears, saliva, colostrum, GI and respiratory mucus). Acquires a Secretory Component from the polymeric Ig receptor (pIgR) during transepithelial transport, resisting enzymatic degradation in mucosal lumens. Inhibits microbial adherence to mucosal surfaces.
IgM: Monomer on naive B-cell surfaces; pentamer joined by a J-chain when secreted. Produced first during primary immune responses. Possesses 10 antigen-binding sites, conferring highest avidity (overall binding strength). Most potent activator of the classical complement pathway.
IgE: Monomer. Maintains extremely low serum concentrations. Binds high-affinity F c ϵ R I Fc\epsilon RI F cϵ R I receptors on mast cells and basophils. Cross-linking of surface IgE by allergen induces immediate degranulation (histamine, leukotrienes), driving Type I hypersensitivity. Mediates eosinophil-dependent ADCC against helminths.
IgD: Monomer. Co-expressed with IgM on the surface of mature naive B cells via alternative RNA splicing. Functions as an antigen receptor involved in B-cell maturation.